Exencial Wealth Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Exencial Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.09 - $1.89 $186,149 - $322,772	-170,779 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$1.44 - $2.73 $18,385 - $34,856	12,768 Added 8.08%	170,779 $311,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $42,400 - $59,167	16,122 Added 11.36%	158,011 $417,000
Q1 2021 May 06, 2021	BUY	$2.82 - $5.6 $140,241 - $278,493	49,731 Added 53.96%	141,889 $511,000
Q4 2020 Feb 11, 2021	BUY	$2.09 - $3.09 $192,610 - $284,768	92,158 New	92,158 $232,000

106K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $141M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.